TY  - JOUR
AU  - Fernández, Adrián
AU  - Navarro Zapata, Alfonso
AU  - Escudero, Adela
AU  - Matamala, Nerea
AU  - Ruz Caracuel, Beatriz
AU  - Mirones, Isabel
AU  - Pernas, Alicia
AU  - Cobo, Marta
AU  - Casado, Gema
AU  - Lanzarot, Diego
AU  - Rodríguez Antolín, Carlos
AU  - Vela, María
AU  - Ferreras, Cristina
AU  - Mestre, Carmen
AU  - Viejo, Aurora
AU  - Leivas, Alejandra
AU  - Martínez, Joaquín
AU  - Fernández, Lucía
AU  - Pérez Martínez, Antonio
PY  - 2021
DO  - 10.3390/cancers13030577
SN  - 2072-6694
UR  - https://hdl.handle.net/20.500.14352/7352
T2  - Cancers
AB  - Natural killer (NK) cells represent promising tools for cancer immunotherapy. We report the optimization of an NK cell activation–expansion process and its validation on clinical-scale. Methods: RPMI-1640, stem cell growth medium (SCGM), NK MACS and...
LA  - eng
M2  - 577
PB  - MDPI
KW  - NK cell immunotherapy
KW  - NK cell activation and expansion
KW  - NKAE cells
KW  - Clinical-grade manufacturing
KW  - CliniMACS Prodigy
TI  - Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy
TY  - journal article
VL  - 13
ER  -